Liquid Biopsy Market - Industry Analysis, Forecast & Trends | BIS Research

1
Liquid Biopsy Market -
res
A Global and Regional Analysis
Table of Content
Focus on Offering, Usage, Workflow, Circulating
Biomarker, Sample, Technology,
Clinical Application, End User, and
Region Analysis and Forecast 2022-2032 May 2022
T E K R A M Y S P O I B D I U Q I L L
A B
O L G All rights reserved at BIS Research
Inc. 1
2
BIS Research is a leading market intelligence and
technology research company. BIS Research
publishes in- depth market intelligence reports
focusing on the market estimations, technology
analysis, emerging high- growth applications,
deeply segmented granular country-level market
data and other important market parameters
useful in the strategic decision making for
senior management. BIS Research provides
multi-client reports, company profiles,
databases, and custom research services.
Copyright 2022 BIS Research Inc. All Rights
Reserved. This document contains highly
confidential information and is the sole property
of BIS Research. Disclosing, copying,
circulating, quoting, or otherwise reproducing
any or all contents of this document is strictly
prohibited. Access to this information is
provided exclusively for the benefit of the
people or organization concerned. It may not be
accessed by or offered, whether for sale or
otherwise, to any third party.
GLOBAL LIQUID BIOPSY MARKET
3
Table of Content Executive Summary................
..................................................
........25 1. Market .............................
..................................................
........36 1.1 Product Definition.................
..................................................
.........................37 1.2 Inclusion and
Exclusion.........................................
.........................................37 2. Mar
ket Scope ........................................
....................................38 2.1 Key
Questions Answered in the Report..................
.......................................39 3. Resea
rch Methodology ..................................
............................40 3.1 Data
Sources...........................................
..................................................
.......41 3.1.1 Primary Data Source
..................................................
.................................41 3.1.2
Secondary Data Sources ...........................
.................................................4
2 3.2 Market Estimation Model.....................
..................................................
..........42 3.3 Criteria for Company
Profiling.........................................
...............................44 4. Market
Overview..........................................
..............................45 4.1 Addressable
Market Size and Growth Potential..................
..........................46 4.2 COVID-19 Impact
on Global Liquid Biopsy Market ...................
....................47 4.2.1 Impact on Market
Size..............................................
...................................48 5. Industry
Insights .........................................
...............................50 5.1 Recently
Launched Product/Services.........................
...................................50 5.1.1
Recently Launched Product/Services by Major
Players ..........................50
5.2 Regulatory Framework .........................
..................................................
.........51 5.2.1 Regulatory Framework in the
U.S ..............................................
................51 5.2.1.1 Guidelines
Recommendation....................................
.........................................
51 5.2.2 Regulatory Framework in the European
Union (EU) ................................51
5.2.3 Regulation in Other Countries...............
..................................................
...52 5.3 Reimbursement Scenario.................
..................................................
.............52 5.4 Financing Scenario...........
..................................................
.............................53 5.4.1 Key
Players Patent Portfolio .........................
.............................................53 5.
4.2 Key Players Stratification As per Raised
Financing Value ......................55
GLOBAL LIQUID BIOPSY MARKET
4

• 5.4.3 Key Players Financing Analysis (by
  Company)........................................55
  
• 5.4.4 Financing Analysis, Million,
  FY2019-FY2022 ....................................
  ......56
• 5.5 Supply Chain Analysis ........................
  ..................................................
  ..........57
• 5.6 Product Mapping Analysis......................
  ..................................................
  ......58
• 5.6.1 By Technology.............................
  ..................................................
  ..............58
• 5.6.2 By Sample Type............................
  ..................................................
  .............59
• 5.6.3 By Circulating Biomarker
  ..................................................
  .........................61
• 5.6.4 By Application ...........................
  ..................................................
  ................62
• 5.7 Global Liquid Biopsy Market Stakeholder
  Analysis (N30) ........................63 5.7.1
  Physicians Perception ...........................
  ..................................................
  ..63
• 5.7.1.1 Technology Used for Liquid Biopsy
  ..................................................
  ................. 63
• Factors Increasing the Adoption of NGS Based
  Liquid Biopsy.......................... 64
• Treatment Guidelines for Different Types of
  Cancer .........................................
  65 5.7.1.4 Challenges for Liquid Biopsy
  ..................................................
  ........................... 65 5.7.2 Payers
  Perception .......................................
  ...............................................66
  5.7.2.1 Average Cost by Technology (N30)
  ..................................................
  .............. 66 5.7.2.2 Cost Difference across
  End Users.........................................
  ............................ 67
• 5.7.2.3 Key Factors for Determining Reimbursement
  Possibility................................... 67
  5.7.3 Investors Perception .....................
  ..................................................
  ...........68 5.8 Liquid Biopsy Government
  Initiatives ......................................
  .....................69
• 6. Market Dynamics ...............................
  ........................................70
• 6.1 Market Drivers................................
  ..................................................
  ................70
• 6.1.1 Rising Cancer Prevalence
  ..................................................
  ........................70
• Increasing Adoption of Inorganic Growth
  Strategies in the Market........72
• Increased Research Funding from National Cancer
  Institute .................73 6.2 Market
  Challenges .......................................
  ..................................................
  ..75
• Uncertain Reimbursement and Regulatory Policies
  ................................75

GLOBAL LIQUID BIOPSY MARKET
5

• 6.3.1 Potential Cost Savings....................
  ..................................................
  ..........75
• 6.3.2 Existing Applicability in Non-Availability
  of Tissue Sections for Conventional Biopsy
  Approaches .......................................
  ......................76
• 7. Competitive Insights ..........................
  ........................................77
• 7.1 Corporate Strategies .........................
  ..................................................
  ............77
• 7.1.1 Synergistic Activities ...................
  ..................................................
  .............77
• 7.1.2 Acquisitions ..............................
  ..................................................
  .................78
• 7.1.3 Funding and Business Expansion Activities
  ............................................79
  7.2 Business Strategies ..........................
  ..................................................
  ............80
• 7.2.1 Service/Product Launches
  ..................................................
  .......................80
• 7.3 Market Share Analysis (by Manufacturers)
  ..................................................
  .81
• 7.4 Market Share Analysis (by Service
  Providers)........................................
  ......82
• Global Liquid Biopsy Market, by Offering,
  Million, 2021-2032....84
• 8.1 Overview......................................
  ..................................................
  ...................85
• 8.2 Testing Service ..............................
  ..................................................
  ................86
• 8.3 Kits .........................................
  ..................................................
  .........................87
• 8.4 Platform .....................................
  ..................................................
  .....................88
• 8.5 Other Consumables.............................
  ..................................................
  ..........89
• Global Liquid Biopsy Market, by Technology,
  Million, 2021- 2032 ............................
  ..................................................
  ............91
• 9.1 Overview......................................
  ..................................................
  ...................92
• 9.2 Next-Generation Sequencing....................
  ..................................................
  ....92

GLOBAL LIQUID BIOPSY MARKET
6

• 10.1 Overview...................................
  ..................................................
  ....................101
• 10.2 Sample Preparation .......................
  ..................................................
  ..............102
• 10.3 Library Preparation.......................
  ..................................................
  ...............102
• 10.4 Sequencing ...............................
  ..................................................
  ...................103
• 10.5 Data Analysis and Management
  ..................................................
  .................105
• Global Liquid Biopsy Market, by Usage, Million,
  2021-2032 .... 106
• 11.1 Overview...................................
  ..................................................
  ....................107
• 11.2 Clinical .................................
  ..................................................
  .........................108
• 11.3 Research .................................
  ..................................................
  .....................108
• Global Liquid Biopsy Market, by Sample, Million,
  2021-2032... 110 12.1 Overview...................
  ..................................................
  ....................................111 12.2
  Blood ............................................
  ..................................................
  ................112
• 12.3 Urine ....................................
  ..................................................
  .........................112
• 12.4 Saliva ...................................
  ..................................................
  .........................113
• 12.5 Others ...................................
  ..................................................
  ........................114
• Global Liquid Biopsy Market, by Circulating Biomar
  ker,
• Million, 2021-2032 ..............................
  .................................... 115
• 13.1 Overview...................................
  ..................................................
  ....................116
• 13.2 Circulating Tumor Cells
  (CTCs)............................................
  ........................117
• 13.3 Cell-Free DNA (cfDNA) ....................
  ..................................................
  ............118
• 13.4 Circulating Cell-Free RNAs
  ..................................................
  .........................118

GLOBAL LIQUID BIOPSY MARKET
7

• 14.6 Melanoma ....................................
  ..................................................
  .................127
• 14.7 Other Types of Cancer .......................
  ..................................................
  .........128
• 14.8 Non-Oncology Disorder .......................
  ..................................................
  .......129
• Global Liquid Biopsy Market, by Clinical
  Application, Million, 2021-2032.................
  ..................................................
  ............. 130
• 15.1 Overview.....................................
  ..................................................
  ..................131
• 15.2 Treatment Monitoring ........................
  ..................................................
  ..........132
• 15.3 Prognosis and Recurrence Monitoring..........
  ..............................................132
  15.4 Treatment Selection ........................
  ..................................................
  ............133
• 15.5 Diagnosis and Screening .....................
  ..................................................
  .......134
• Global Liquid Biopsy Market, by End User,
  Million, 2021-2032
• ..................................................
  ..............................................
  136
• 16.1 Overview.....................................
  ..................................................
  ..................137
• 16.1.1 Academic and Research Institutions.........
  ..............................................138
• 16.1.2 Clinical Laboratories .....................
  ..................................................
  ..........138
• 16.1.3 Pharmaceutical and Biotechnology
  Companies.....................................139
  16.1.4 Other End Users ..........................
  ..................................................
  ............140
• 17. Region .......................................
  ..............................................
  141
• 17.1 Overview.....................................
  ..................................................
  ..................142
• 17.2 North America ...............................
  ..................................................
  ...............144
• 17.2.1 U.S. ......................................
  ..................................................
  .....................146
• 17.2.2 Canada ....................................
  ..................................................
  .................148

GLOBAL LIQUID BIOPSY MARKET
8
17.4.1 China .....................................
..................................................
...................165 17.4.2 Japan
..................................................
..................................................
......167 17.4.3 India ...........................
..................................................
...............................168 17.4.4
Australia ........................................
..................................................
...........169 17.4.5 South Korea
..................................................
.............................................171 1
7.4.6 Singapore ..................................
..................................................
...............172 17.4.7 Rest-of-Asia-Pacific....
..................................................
.............................173 17.5 Latin
America and Middle East...........................
..........................................175 17.5
.1 Brazil.........................................
..................................................
................177 17.5.2 Mexico
..................................................
..................................................
....178 17.5.3 Saudi Arabia ......................
..................................................
......................180 17.5.4 Rest-of-Latin
America and Middle East ..........................
.........................181 17.6 Rest-of-the-Worl
d ................................................
..........................................182 18.
Market - Competitive Benchmarking Company
Profiles ......... 184 18.1 Overview..............
..................................................
.........................................185 18.2
Abcodia Ltd. .....................................
..................................................
............186 18.2.1 Company Overview
..................................................
.................................186 18.2.2 Role
of Abcodia Ltd. in the Liquid Biopsy Market
..................................186 18.2.3 Key
Customers of the Company .........................
.....................................186 18.2.4
Key Competitors of the Company....................
........................................187 18.2.5
Corporate Strategies ............................
..................................................
...187 18.2.6 Analyst Perspective
..................................................
................................188 18.3 Bio-Rad
Laboratories, Inc. ...............................
.............................................189 1
8.3.1 Company Overview ...........................
..................................................
......189 18.3.2 Role of Bio-Rad Laboratories,
Inc. in the Global Liquid Biopsy
Market............................................
..................................................
...........189 18.3.3 Key Competitors of the
Company...........................................
.................189 18.3.4 Key Customers of the
Company ..........................................
....................190 18.3.5 Corporate
Strategies .......................................
..........................................190 18.3
.6 Financials ....................................
..................................................
.............191
GLOBAL LIQUID BIOPSY MARKET
9
18.3.7 Key Insights about the Financial Health of
the Company......................193 18.3.8
Analysts Perspective ............................
..................................................
.193 18.4 Biocept, Inc. ..........................
..................................................
.......................194 18.4.1 Company
Overview .........................................
..........................................194 18.4
.2 Role of Biocept, Inc. in the Global Liquid
Biopsy Market ......................194 18.4.3
Key Customers of the Company .....................
.........................................194 18.4.
4 Key Competitors of the Company..................
..........................................194 18.4
.5 Corporate Strategies ..........................
..................................................
.....195 18.4.6 Business Strategies
..................................................
................................195 18.4.7
Financials .......................................
..................................................
..........196 18.4.8 Key Insights about the
Financial Health of the Company...................
...196 18.4.9 Analysts Perspective
..................................................
.............................197 18.5 Dxcover
Limited...........................................
..................................................
198 18.5.1 Company Overview ......................
..................................................
...........198 18.5.2 Role of Dxcover Limited in
the Global Liquid Biopsy Market................198
18.5.3 Key Customers of the Company
..................................................
............198 18.5.4 Key Competitors of the
Company...........................................
.................198 18.5.5 Dxcover Platform
Workflow..........................................
............................199 18.5.6
Collaboration and Partnership of Dxcover Limited
................................200 18.5.7
Corporate Strategies .............................
..................................................
..200 18.5.8 Analyst Perspective
..................................................
................................201 18.6 Elypta
..................................................
..................................................
..........202 18.6.1 Company Overview
..................................................
.................................202 18.6.2 Role
of Elypta Limited in the Global Liquid Biopsy
Market ...................202 18.6.3 Key
Customers of the Company .........................
.....................................202 18.6.4
Key Competitors of the Company....................
........................................202 18.6.5
Corporate Strategies ............................
..................................................
...203 18.6.6 Analysts Perspective
..................................................
.............................203 18.7 Epic
Sciences..........................................
..................................................
.....204 18.7.1 Company Overview
..................................................
.................................204
GLOBAL LIQUID BIOPSY MARKET
10
18.7.2 Role of Epic Sciences in the Global Liquid
Biopsy Market ...................204 18.7.3 Key
Customers of the Company .........................
.....................................204 18.7.4
Key Competitors of the Company....................
........................................204 18.7.5
Corporate Strategies ............................
..................................................
...205 18.7.6 Analysts Perspective
..................................................
.............................205 18.8 F.
Hoffmann-La Roche Ltd ............................
................................................20
6 18.8.1 Company Overview ........................
..................................................
.........206 18.8.2 Role of F. Hoffmann-La Roche
Ltd in the Global Liquid Biopsy
Market............................................
..................................................
...........206 18.8.3 Key Competitors of the
Company...........................................
.................206 18.8.4 Key Customers of the
Company ..........................................
....................206 18.8.5 Business
Strategies .......................................
...........................................207 18.
8.6 Financials ...................................
..................................................
..............207 18.8.7 Key Insights about the
Financial Health of the Company...................
...209 18.8.8 Analysts Perspective
..................................................
.............................210 18.9 Guardant
Health............................................
.................................................2
11 18.9.1 Company Overview ......................
..................................................
...........211 18.9.2 Role of Guardant Health in
the Global Liquid Biopsy Market................211
18.9.3 Key Customers of the Company
..................................................
............211 18.9.4 Key Competitors of the
Company...........................................
.................212 18.9.5 Business Strategies
..................................................
................................212 18.9.6
Financials .......................................
..................................................
..........213 18.9.7 Key Insights about the
Financial Health of the Company...................
...215 18.9.8 Analysts Perspective
..................................................
.............................215 18.10 Illumina,
Inc. .............................................
..................................................
....216 18.10.1 Company Overview.................
..................................................
..........216 18.10.2 Role of Illumina, Inc. in
the Global Liquid Biopsy Market
...............216 18.10.3 Key Competitors of
the Company ......................................
...............216 18.10.4 Key Customers of the
Company...........................................
.............216 18.10.5 Corporate
Strategies........................................
...................................217
GLOBAL LIQUID BIOPSY MARKET
11
18.10.6 Financials ...............................
..................................................
...........217 18.10.7 Key Insights about the
Financial Health of the Company
...............219 18.10.8 Analysts Perspective
..................................................
.......................220 18.11 Laboratory
Corporation of America Holdings...................
..........................221 18.11.1 Company
Overview..........................................
...................................221 18.11.2 Rol
e of Laboratory Corporation of America Holdings
in the Global Liquid Biopsy Market
..................................................
..................221 18.11.3 Key Customers of
the Company.......................................
.................221 18.11.4 Key Competitors of
the Company ......................................
...............222 18.11.5 Corporate
Strategies........................................
...................................222 18.11.6 Fin
ancials ..........................................
..................................................
223 18.11.7 Analysts Perspective
..................................................
.......................225 18.12 LungLife AI,
Inc...............................................
...............................................226
18.12.1 Company Overview.........................
..................................................
..226 18.12.2 Role of LungLife AI, Inc. in the
Global Liquid Biopsy Market .........226
18.12.3 Key Customers of the Company..............
..........................................226 18.1
2.4 Key Competitors of the Company
..................................................
...226 18.12.5 Corporate Strategies...............
..................................................
..........227 18.12.6 Analysts Perspective
..................................................
.......................227 18.13
Micronoma.........................................
..................................................
...........228 18.13.1 Company Overview...........
..................................................
................228 18.13.2 Role of Micronoma in
the Global Liquid Biopsy Market
..................228 18.13.3 Key Competitors of
the Company ......................................
...............228 18.13.4 Micronoma Oncobiota
Platform Design Overview..........................
229 18.13.5 Research Partners of Micronoma
..................................................
....229 18.13.6 Investors of Micronoma............
..................................................
........230 18.13.7 Corporate Strategies..........
..................................................
...............230 18.13.8 Analyst Perspectives
..................................................
........................230 18.14 Natera, Inc.
..................................................
..................................................
.231 18.14.1 Company Overview.....................
..................................................
......231
GLOBAL LIQUID BIOPSY MARKET
12
18.14.2 Role of Natera, Inc. Limited in the
Global Liquid Biopsy Market ....231 18.14.3 Key
Customers of the Company..........................
..............................232 18.14.4 Key
Competitors of the Company .......................
..............................232 18.14.5 Corporat
e Strategies......................................
.....................................232 18.14.6 F
inancials ........................................
..................................................
..233 18.14.7 Key Insights about the
Financial Health of the Company
...............234 18.14.8 Analysts Perspective
..................................................
.......................234 18.15 Neogenomics
Laboratories......................................
.....................................236 18.15.1 C
ompany Overview...................................
..........................................236 18.1
5.2 Role of Neogenomics Laboratories in the
Global Liquid Biopsy Market......................
..................................................
.................................236 18.15.3 Key
Competitors of the Company .......................
..............................236 18.15.4 Key
Customers of the Company..........................
..............................236 18.15.5 Corporat
e Strategies......................................
.....................................237 18.15.6 F
inancials ........................................
..................................................
..237 18.15.7 Key Insights about the
Financial Health of the Company
...............238 18.15.8 Analysts Perspective
..................................................
.......................239 18.16 PerkinElmer
Inc...............................................
...............................................240
18.16.1 Company Overview....................
..................................................
.......240 18.16.2 Role of PerkinElmer Inc. in
the Global Liquid Biopsy Market .........240
18.16.3 Key Competitors of the Company
..................................................
...240 18.16.4 Key Customers of the
Company...........................................
.............240 18.16.5 Corporate
Strategies........................................
...................................241 18.16.6
Financials ....................................
..................................................
......241 18.16.7 Key Insights about the
Financial Health of the Company
...............243 18.16.8 Analysts
Perspective ......................................
...................................244 18.17
QIAGEN ...........................................
..................................................
.............245 18.17.1 Company
Overview..........................................
...................................245 18.17.2
Role of QIAGEN in the Global Liquid Biopsy Market
.......................245 18.17.3 Key
Competitors of the Company .......................
..............................245
GLOBAL LIQUID BIOPSY MARKET
13
18.17.4 Key Customers of the Company..............
..........................................246 18.1
7.5 Corporate Strategies..........................
.................................................2
46 18.17.6 Business Strategies....................
..................................................
......246 18.17.7 Financials .....................
..................................................
.....................247 18.17.8 Key Insights
about the Financial Health of the Company
...............249 18.17.9 Analysts Perspective
..................................................
.......................249 18.18 Sysmex
Corporation.......................................
...............................................251
18.18.1 Company Overview.........................
..................................................
..251 18.18.2 Role of Sysmex Corporation in the
Global Liquid Biopsy Testing Market..............
..................................................
.........................................251 18.18
.3 Key Competitors of the Company
..................................................
...251 18.18.4 Key Customers of the
Company...........................................
.............251 18.18.5 Corporate
Strategies........................................
...................................252 18.18.6 Bus
iness Strategies..................................
..........................................252 18.1
8.7 Financials ...................................
..................................................
.......253 18.18.8 Key Insights about the
Financial Health of the Company
...............254 18.18.9 Analysts Perspective
..................................................
.......................255 18.19 Thermo Fisher
Scientific Inc....................................
.....................................256 18.19.1 C
ompany Overview...................................
..........................................256 18.1
9.2 Role of Thermo Fisher Scientific Inc. in the
Global Liquid Biopsy Market......................
..................................................
.................................256 18.19.3 Key
Competitors of the Company .......................
..............................257 18.19.4 Key
Customers of the Company..........................
..............................257 18.19.5 Corporat
e Strategies......................................
.....................................257 18.19.6 F
inancials ........................................
..................................................
..258 18.19.7 Key Insights about the Financial
Health of the Company ...............260
18.19.8 Analysts Perspective ....................
..................................................
...260
GLOBAL LIQUID BIOPSY MARKET
14
List of Figures
Figure 1 Type of Cancer Diagnostics
Figure 2 Global Liquid Biopsy Market Dynamics
Figure 3 Global Liquid Biopsy Market (by Technology), Million, 2021 and 2032
Figure 4 Global Liquid Biopsy Market (by Workflow), Million, 2021 and 2032
Figure 5 Global Liquid Biopsy Market (by Usage), Million, 2021 and 2032
Figure 6 Global Liquid Biopsy Market (by Sample), Million, 2021 and 2032
Figure 7 Global Liquid Biopsy Market (by Circulating Biomarker), Million, 2021 and 2032
Figure 8 Global Liquid Biopsy Market (by Offering), Million, 2021 and 2032
Figure 9 Global Liquid Biopsy Market (by Indication), Million, 2021 and 2032
Figure 10 Global Liquid Biopsy Market (by Clinical Application), Million, 2021 and 2032
Figure 11 Global Liquid Biopsy Market (by End User), Million, 2021 and 2032
Figure 12 Global Liquid Biopsy Market (by Region), Million, 2021
Figure 13 Global Liquid Biopsy Market Segmentation
Figure 14 Global Liquid Biopsy Market Research Methodology
Figure 15 Primary Research Methodology
Figure 16 Bottom-Up Approach (Segment-Wise Analysis)
Figure 17 Top-Down Approach (Segment-Wise Analysis)
Figure 18 Global Liquid Biopsy Market, Million, 2021-2032
Figure 19 Global Liquid Biopsy Market, Million, 2021-2032
Figure 20 Pre-COVID-19 and Post-COVID-19 Scenario of Global Liquid Biopsy Market, Million, 2020- 2026
Figure 21 Impact of COVID-19 on Liquid Biopsy Market
Figure 22 Financing Analysis (by Company), Million, FY2019-FY2022
Figure 23 Liquid Biopsy Supply Chain Analysis
Figure 24 Global Liquid Biopsy Market Dynamics
Figure 25 Number of New Cases of Cancer, 2020
Figure 26 Share of Different Cancer Patients
Figure 27 Synergistic Activities, 2020-2021
Figure 28 Research Funding for Different Cancer Types, 2020
Figure 29 Year-on-Year Fiscal Budget of NCI, Million, 2015-2020
Figure 30 Share of Key Developments and Strategies, January 2019-May 2022
GLOBAL LIQUID BIOPSY MARKET
15
Figure 31 Synergistic Activities Share (by Company), January 2019-May 2022
Figure 32 Acquisitions Share (by Company), January 2019-May 2022
Figure 33 Funding and Business Expansion Activities (by Company), January 2019-May 2022
Figure 34 Service/Product Launches (by Company), January 2019-May 2022
Figure 35 Global Liquid Biopsy Market Share Analysis (by Product Manufacturers), 2020 and 2021
Figure 36 Global Liquid Biopsy Market Share Analysis (Service Providers), 2020 and 2021
Figure 37 Global Liquid Biopsy Market (by Offering)
Figure 38 Share of Global Liquid Biopsy Market (by Offering), Million, 2021 and 2032
Figure 39 Global Liquid Biopsy Market (Testing Service), Million, 2021-2032
Figure 40 Global Liquid Biopsy Market (Kits), Million, 2021-2032
Figure 41 Global Liquid Biopsy Market (Platform), Million, 2021-2032
Figure 42 Global Liquid Biopsy Market (Other Consumables), Million, 2021-2032
Figure 43 Global Liquid Biopsy Market (by Technology), Million, 2021 and 2032
Figure 44 Global Liquid Biopsy Market (Next-Generation Sequencing), Million, 2021-2032
Figure 45 Global Liquid Biopsy Market (Polymerase Chain Reaction), Million, 2021-2032
Figure 46 Global Liquid Biopsy Market (Digital PCR), Million, 2021-2032
Figure 47 Global Liquid Biopsy Market (Multiplex PCR), Million, 2021-2032
Figure 48 Global Liquid Biopsy Market (Real-Time PCR), Million, 2021-2032
Figure 49 Global Liquid Biopsy Market (Others), Million, 2021-2032
Figure 50 Global Liquid Biopsy Market (Other Technologies), Million, 2021-2032
Figure 51 Global Liquid Biopsy Market (by Emerging Technologies), Million, 2021-2032
Figure 52 Global Liquid Biopsy Market (by Workflow)
Figure 53 Global Liquid Biopsy Market (by Workflow), 2021 vs. 2032
Figure 54 Global Liquid Biopsy Market (Sample Preparation), 2021-2032
Figure 55 Global Liquid Biopsy Market (Library Preparation), 2021-2032
Figure 56 Global Liquid Biopsy Market (Sequencing), 2021-2032
Figure 57 Global Liquid Biopsy Market (Data Analysis and Management), 2021-2032
Figure 58 Global Liquid Biopsy Market (by Usage)
Figure 59 Global Liquid Biopsy Market (by Usage), 2021 vs. 2032
Figure 60 Global Liquid Biopsy Market (Clinical), 2021-2032
Figure 61 Global Liquid Biopsy Market (Research), 2021-2032
Figure 62 Global Liquid Biopsy Market (by Sample)
Figure 63 Global Liquid Biopsy Market (by Sample), 2021 vs. 2032
GLOBAL LIQUID BIOPSY MARKET
16
Figure 64 Global Liquid Biopsy Market (Blood), 2021-2032
Figure 65 Global Liquid Biopsy Market (Urine), 2021-2032
Figure 66 Global Liquid Biopsy Market (Saliva), 2021-2032
Figure 67 Global Liquid Biopsy Market (by Others), 2021-2032
Figure 68 Global Liquid Biopsy Market (by Circulating Biomarker
Figure 69 Global Liquid Biopsy Market (by Circulating Biomarker), 2021 vs. 2032
Figure 70 Global Liquid Biopsy Market (Circulating Tumor Cells), 2021-2032
Figure 71 Global Liquid Biopsy Market (Cell-Free DNA), 2021-2032
Figure 72 Global Liquid Biopsy Market (Circulating Cell-Free RNAs), 2021-2032
Figure 73 Global Liquid Biopsy Market (Exosomes and Extracellular Vesicles), 2021-2032
Figure 74 Global Liquid Biopsy Market (by Other Circulating Biomarkers), 2021-2032
Figure 75 Global Liquid Biopsy Market (by Indication)
Figure 76 Global Liquid Biopsy Market (by Indication), 2021 vs. 2032
Figure 77 Global Liquid Biopsy Market (Breast Cancer), 2021-2032
Figure 78 Global Liquid Biopsy Market (Prostate Cancer), 2021-2032
Figure 79 Global Liquid Biopsy Market (Lung Cancer), 2021-2032
Figure 80 Global Liquid Biopsy Market (Colorectal Cancer), 2021-2032
Figure 81 Global Liquid Biopsy Market (Melanoma), 2021-2032
Figure 82 Global Liquid Biopsy Market (by Other Types of Cancer), 2021-2032
Figure 83 Global Liquid Biopsy Market (Non-Oncology Disorder), 2021-2032
Figure 84 Global Liquid Biopsy Market (by Clinical Application)
Figure 85 Global Liquid Biopsy Market (by Clinical Application), 2021 vs. 2032
Figure 86 Global Liquid Biopsy Market (Treatment Monitoring), 2021-2032
Figure 87 Global Liquid Biopsy Market (Prognosis and Recurrence Monitoring), 2021-2032
Figure 88 Global Liquid Biopsy Market (Treatment Selection), 2021-2032
Figure 89 Global Liquid Biopsy Market (Diagnosis and Screening), 2021-2032
Figure 90 Global Liquid Biopsy Market (by End User), 2021 vs. 2032
Figure 91 Global Liquid Biopsy Market (Academic and Research Institutions), Million, 2021-2032
Figure 92 Global Liquid Biopsy Market (Clinical Laboratories), Million, 2021-2032
Figure 93 Global Liquid Biopsy Market (Pharmaceutical and Biotechnology Companies), Million, 2021- 2032
Figure 94 Global Liquid Biopsy Market (Other End Users), Million, 2021-2032
Figure 95 Global Liquid Biopsy Market (by Region), Million, 2021-2032
GLOBAL LIQUID BIOPSY MARKET
17
Figure 96 Figure 97 Figure 98 Figure 99 Global Liquid Biopsy Market (by North America), 2021 vs. 2032 North America Liquid Biopsy Market, Million, 2021-2032 North America Liquid Biopsy Market, Thousand Units, 2021-2032 Market Dynamics of North America Liquid Biopsy Market
Figure 100 U.S. Liquid Biopsy Market, 2021-2032
Figure 101 U.S. Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 102 Canada Liquid Biopsy Market, 2021-2032
Figure 103 Canada Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 104 Global Liquid Biopsy Market (by Europe), 2021 vs. 2032
Figure 105 Europe Liquid Biopsy Market, Million, 2021-2032
Figure 106 Europe Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 107 Market Dynamics of the Europe Liquid Biopsy Market
Figure 108 Germany Liquid Biopsy Market, 2021-2032
Figure 109 Germany Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 110 France Liquid Biopsy Market, 2021-2032
Figure 111 France Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 112 U.K. Liquid Biopsy Market, 2021-2032
Figure 113 U.K. Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 114 Italy Liquid Biopsy Market, 2021-2032
Figure 115 Italy Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 116 Spain Liquid Biopsy Market, 2021-2032
Figure 117 Spain Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 118 Rest-of-Europe Liquid Biopsy Market, 2021-2032
Figure 119 Rest-of-Europe Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 120 Global Liquid Biopsy Market (by Asia-Pacific), 2021 vs. 2032
Figure 121 Asia-Pacific Liquid Biopsy Market, Million, 2021-2032
Figure 122 Asia-Pacific Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 123 Market Dynamics of Asia-Pacific Liquid Biopsy Market
Figure 124 China Liquid Biopsy Market, 2021-2032
Figure 125 China Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 126 Japan Liquid Biopsy Market, 2021-2032
Figure 127 Japan Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 128 India Liquid Biopsy Market, 2021-2032
GLOBAL LIQUID BIOPSY MARKET
18
Figure 129 India Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 130 Australia Liquid Biopsy Market, 2021-2032
Figure 131 Australia Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 132 South Korea Liquid Biopsy Market, 2021-2032
Figure 133 South Korea Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 134 Singapore Liquid Biopsy Market, 2021-2032
Figure 135 Singapore Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 136 Rest-of-Asia-Pacific Liquid Biopsy Market, 2021-2032
Figure 137 Rest-of-Asia-Pacific Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 138 Global Liquid Biopsy Market (by Latin America and Middle East), 2021 vs. 2032
Figure 139 Latin America and Middle East Liquid Biopsy Market, Million, 2021-2032
Figure 140 Latin America and Middle East Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 141 Market Dynamics of Latin America and Middle Eastern Liquid Biopsy Market
Figure 142 Brazil Liquid Biopsy Market, 2021-2032
Figure 143 Brazil Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 144 Mexico Liquid Biopsy Market, 2021-2032
Figure 145 Mexico Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 146 Saudi Arabia Liquid Biopsy Market, 2021-2032
Figure 147 Saudi Arabia Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 148 Rest-of-Latin America and Middle East Liquid Biopsy Market, 2021-2032
Figure 149 Rest-of-Latin America and Middle East Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 150 Rest-of-the-World Liquid Biopsy Market, 2021-2032
Figure 151 Rest-of-the-World Liquid Biopsy Market, Thousand Units, 2021-2032
Figure 152 Total Number of Companies Profiled
Figure 153 Abcodia Ltd. Product Portfolio
Figure 154 Bio-Rad Laboratories, Inc. Overall Product Portfolio
Figure 155 Bio-Rad Laboratories, Inc. Overall Financials, 2019-2021
Figure 156 Bio-Rad Laboratories, Inc. Revenue (by Segment), 2019-2021
Figure 157 Bio-Rad Laboratories, Inc. Revenue (by Region), 2019-2021
Figure 158 Bio-Rad Laboratories, Inc. RD Expenditure, 2019-2021
Figure 159 Biocept, Inc. Portfolio
Figure 160 Biocept, Inc. Overall Financials, 2019-2021
Figure 161 Biocept, Inc. RD Expenditure, 2019-2021
GLOBAL LIQUID BIOPSY MARKET
19
Figure 162 Dxcover Limited Product Portfolio
Figure 163 Dxcover Limited Dxcover Platform Workflow
Figure 164 Dxcover Limited Collaboration and Partnership of Dxcover Limited
Figure 165 Elypta Product Portfolio
Figure 166 Epic Sciences Portfolio
Figure 167 F. Hoffmann-La Roche Ltd Overall Product Portfolio
Figure 168 F. Hoffmann-La Roche Ltd Overall Financials, 2019-2021
Figure 169 F. Hoffmann-La Roche Ltd Revenue (by Segment), 2019-2021
Figure 170 F. Hoffmann-La Roche Ltd Revenue (by Region), 2019-2021
Figure 171 F. Hoffmann-La Roche Ltd RD Expenditure, 2018-2020
Figure 172 Guardant Health Portfolio
Figure 173 Guardant Health Overall Financials, 2019-2021
Figure 174 Guardant Health Sales (by Segment), 2019-2021
Figure 175 Guardant Health Sales (by Region), 2019-2021
Figure 176 Guardant Health RD Expenditure, 2019-2021
Figure 177 Illumina, Inc. Product Portfolio
Figure 178 Illumina, Inc. Overall Financials, Million, 2019-2021
Figure 179 Illumina, Inc. Revenue (by Segment), Million, 2019-2021
Figure 180 Illumina, Inc. Revenue (by Region), Million, 2019-2021
Figure 181 Illumina, Inc. RD Expenditure, Million, 2019-2021
Figure 182 Laboratory Corporation of America Holdings Overall Product Portfolio
Figure 183 Laboratory Corporation of America Holdings Overall Financials, 2019-2021
Figure 184 Laboratory Corporation of America Holdings Revenue (by Segment), 2019-2021
Figure 185 Laboratory Corporation of America Holdings Revenue (by Region), 2019-2021
Figure 186 LungLife AI, Inc. Portfolio
Figure 187 Micronoma Oncobiota Platform Design Overview
Figure 188 Micronoma Research Partners of Micronoma
Figure 189 Micronoma Product Portfolio
Figure 190 Natera, Inc. Product Portfolio
Figure 191 Natera, Inc. Overall Financials, 2019-2021
Figure 192 Natera, Inc. Sales (by Segment), 2019-2021
Figure 193 Natera, Inc. RD Expenditure, 2019-2021
Figure 194 Neogenomics Laboratories Overall Product Portfolio
GLOBAL LIQUID BIOPSY MARKET
20
Figure 195 Figure 196 Figure 197 Figure 198 Neogenomics Laboratories Overall Financials, 2019-2021 Neogenomics Laboratories Revenue (by Segment), 2019-2021 Neogenomics Laboratories RD Expenditure, 2019-2021 PerkinElmer Inc. Product Portfolio
Figure 199 PerkinElmer Inc. Overall Financials, Million, 2019-2021
Figure 200 PerkinElmer Inc. Revenue (by Segment), Million, 2019-2021
Figure 201 PerkinElmer Inc. Revenue (by Region), Million, 2019-2021
Figure 202 PerkinElmer Inc. RD Expenditure, Million, 2019-2021
Figure 203 QIAGEN Overall Product Portfolio
Figure 204 QIAGEN Overall Financials, 2019-2021
Figure 205 QIAGEN Revenue (by Segment), 2019-2021
Figure 206 QIAGEN Revenue (by Region), 2019-2021
Figure 207 QIAGEN RD Expenditure, 2019-2021
Figure 208 Sysmex Corporation Overall Product Portfolio
Figure 209 Sysmex Corporation Overall Financials, 2018-2020
Figure 210 Sysmex Corporation Revenue (by Region), 2018-2020
Figure 211 Sysmex Corporation RD Expenditure, 2018-2020
Figure 212 Thermo Fisher Scientific Inc. Product Portfolio
Figure 213 Thermo Fisher Scientific Inc. Overall Financials, Million, 2019-2021
Figure 214 Thermo Fisher Scientific Inc. Revenue (by Business Segment), Million, 2019-2021
Figure 215 Thermo Fisher Scientific Inc. Revenue (by Region), Million, 2019-2021
Figure 216 Thermo Fisher Scientific Inc. RD Expenditure, Million, 2019-2021
GLOBAL LIQUID BIOPSY MARKET
21
List of Tables
Table 1
Most Common Cancers
Table 2
Global Liquid Biopsy Market (by Region),
Million, 2021-2032
Table 3
COVID-19 Impact on Global Liquid Biopsy Market
Table 4
Products and Services Launched by Various Key
Players for Liquid Biopsy Research
Table 5
Launched Liquid Biopsy Tests from Major Players
Table 6
Reimbursement Scenario for Key Players' Offerings
in the Global Liquid Biopsy Market
Table 7
Global Liquid Biopsy Market Key Players Patent
Portfolio
Table 8
Liquid Biopsy Product Mapping Analysis (by
Technology)
Table 9
Liquid Biopsy Product Mapping Analysis (by Sample)
Table 10
Liquid Biopsy Product Mapping Analysis (by
Circulating Biomarker)
Table 11
Liquid Biopsy Product Mapping Analysis (by
Application)
Table 12
Government Initiatives for Liquid Biopsies
Table 13
Pricing List of Key Players Liquid Biopsies
Table 14
List of Companies Providing Testing Services
Table 15
List of Companies Providing Kits
Table 16
List of Companies Providing Platform
Table 17
List of Companies Providing Other Consumables
GLOBAL LIQUID BIOPSY MARKET
22
BIS Research Offerings
We are on a mission to harness the potential of
disruptive technologies to make businesses thrive
in todays digital age. We have a vision to be a
leading and a preferred knowledge partner for
corporates and institutions worldwide and assist
them with market intelligence in the area of
emerging technologies, advisories, and other
innovative solutions.
Know More
Know More
Know More
GLOBAL LIQUID BIOPSY MARKET
Know More
23
Disclaimer
BIS Research Inc. provides valuable market
intelligence to an exclusive group of customers
in response to orders. The report is licensed
for the customer's internal use only and is
subject to restrictions set henceforth. This
document and its contents are confidential and
may not be further distributed, published or
reproduced, in whole or in part, by any medium
or in any form for any purpose, without the
express written consent of BIS Research Inc.
Customer will not disclose the contents of the
report, whether directly in any media or
indirectly through incorporation in a database,
marketing list, report or otherwise, or use or
permit the use of Information to generate any
statistical or other information that is or will
be provided to third parties or voluntarily
produce Information in legal proceedings.
Market reports are based on expectations,
estimates and projections as of the date such
information is available. Any recommendation
contained in this report may not be suitable for
all investors or businesses. The market
conclusions drawn are necessarily based upon a
number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of
the date of such statements, are inherently
subject to market fluctuations and business,
economic and competitive uncertainties, and
contingencies
For more details regarding permission, please
contact us Email sales_at_bisresearch.com Tel 1
510 404 8135
GLOBAL LIQUID BIOPSY MARKET
24
BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite
313 Fremont, CA 94538 -1686 E-mail
hello_at_bisresearch.com Call Us 1-510-404-8135
T E K R A M Y S P O I B D I U Q I L L
A B O L G All rights reserved at BIS
Research Inc. 24
Global Delivery Center Tower B First Floor,
Tapasya Corporate Heights, Greater Noida
Expressway, Sector 126, Noida, U.P., 201303,
India Tel [phone]
www.bisresearch.com